GB2089505A - Determination of Transferrine - Google Patents
Determination of Transferrine Download PDFInfo
- Publication number
- GB2089505A GB2089505A GB8136865A GB8136865A GB2089505A GB 2089505 A GB2089505 A GB 2089505A GB 8136865 A GB8136865 A GB 8136865A GB 8136865 A GB8136865 A GB 8136865A GB 2089505 A GB2089505 A GB 2089505A
- Authority
- GB
- United Kingdom
- Prior art keywords
- reagent
- transferrine
- iron
- sample
- solid substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/90—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving iron binding capacity of blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The transferrine content of a sample is determined by adding to the sample a reagent consisting of a ferric salt adsorbed onto the particles of a suspension of a solid substrate, e.g. magnesium carbonate. The mixture obtained is centrifuged and the iron in the supernatant is determined e.g. colorimetrically. A reagent comprising a suspension of a solid substrate on which ferric salt is adsorbed is also claimed. <IMAGE>
Description
SPECIFICATION
Determination of Transferrine
This invention relates to a method for the determination of the iron-binding ability of transferrine, and to a reagent for use in the method.
Transferrine is a glycoprotein contained in blood. It serves to transfer iron, and each molecule thereof can bind two ferric ions.
The transferrine content of blood can be measured either directly by immunological methods, or indirectly by the determination of its iron-binding ability by chemical methods. With respect to the latter methods, there is known, from Clinica Chimica Acta, 2 221 (1957), a method which consists of the steps of (a) saturating the transferrine which is present in the sample, usually a serum sample, with an acidic solution which contains an excess of ferric ions, (b) removing, after incubation, the excess ferric ions by adding solid magnesium carbonate, and (c) determining, after centrifuging the slurry thus obtained, the amount of iron bonded to the transferrine contained in the supernatant, by means of a reagent suitable for the determination of iron.In other procedures, conversely, the excess amount of ferric ions is determined under appropiate conditions and the amount of iron removed by transferrine is then calculated, the amount of transferrine then being determined arithmetically.
We have now found that it is possible to determine the amount of tranferrine contained in a sample without previously saturating the sample with an excess of ferric ions in an acidic environment.
According to the present invention, there is provided a method of determining the transferrine content of a sample suspected of containing transferrine, which method comprises mixing the sample with a reagent comprising a suspension of a solid substrate on which substrate a ferric salt is absorbed, centrifuging the mixture, and determining the iron content of the resulting supernatant liquor.
The present invention also provides a reagent for use in determining the transferrine content of a sample suspected of containing transferrine, the reagent comprising a suspension of a solid substrate on which substrate a ferric salt Is adsorbed.
Thus, the present invention provides a method for the determination of the iron-binding ability of transferrine, in which method there is used a single reagent which comprises a solution of a ferric salt and a slurry of an appropriate solid adsorbant, the reagent being added to the sample whereafter the mixture is centrifuged and the iron bound to the transferrine contained in the supernatant is determined.
A number of advantages are achieved by the method of the invention, at least in preferred embodiments thereof, as compared to the prior art method outlined above. The most significant of them are (a) the procedure is simplified and the number of steps and incubation is lower; (b) fewer manipulative steps are required since it is not necessary to introduce magnesium carbonate in the solid state into the reaction mixture; (c) measurement of the amounts of reagent used is better reproducible; and (d) the tranferrine in the sample is saturated with ferric ions at a basic pH, the latter being suggested by the literature as the most suitable for the binding of transferrine to iron. We consider that these advantages result in a simplicity and an accuracy of determination which cannot be found in the prior art methods.
Preferably, the reagent has a pH of from 8 to 9, and accordingly it preferably contains a buffer capable of maintaining the pH at a value of from 8 to 9. The reagent preferably contains a colorimetric reagent for the determination of iron.
Examples of suitable solid substrates are basic magnesium carbonate and calcium carbonate, the former being preferred.
Examples of suitable buffers are H3PO4, H2PO-4, barbituric acid, and barbiturates. The preferred buffer is NaH2PO4.
If a colorimetric reagent is used, it can be a reagent known from the prior art. Also, it can be a reagent as disclosed and claimed in Italian Patent
Application No. 201 77A/80, which was laid open to public inspection on the 26th August 1981.
The invention will now be illustrated by the following Examples.
Example 1 (Preparation of Reagent)
In 100 ml of water there was dissolved 828 mg of NaH2PO4.H2O. Thereafter, 2.5 g of basic
MgCO3 were added to form a suspension, and, to the suspension, there was added, with stirring, 1 ml of 0.01 normal HCI containing 500 mg/dl of
Fe3+. The reagent was allowed to stand until its pH has stabilized.
Example 2
The reagent described in Example 1 was used for determing the iron-binding power of 48 samples of human blood serum. The average value was 293.71 micrograms/dl of iron, with a
C.V. of 3.48%. In each of determinations, 1 ml of the reagent of Example 1 and 0.2 ml of serum were used, and incubation was carried out for 5 minutes at room temperature and centrifuging for
10 minutes at 4,000 RPM. The iron in the supernatant was drawn and determined with a conventional reagent
Example 3
To fractional samples of a base serum whose iron-binding power had been determined, progressively increased amounts of human transferrine were added.The iron-binding power of the serum samples so enriched was determined according to the procedure set forth in Example 2 above and according to the Ramsey
procedure disclosed in Clinica Chimica Acta, 2 221(1957). The values of the iron-binding power obtained by these two procedures were correlated with the amounts by weight of transferrine added, whereby graphs represented by the following equations were obtained:
(A) y=0.90x+277.2
(correlation coefficient=0.998) (B) y=0.9 1 x+277.5 (correlation coefficient=0.997).
In the above equations, x is the amount of added tranferrine in milligrams and y is the ironbinding power in micrograms/dl of determined iron, equation (A) being that obtained by the procedure of Example 2 and equation (B) being that obtained by the Ramsey procedure.
The value of the iron-binding power of the base serum evaluated by the method of this invention was 281 micrograms/dl, and, by the Ramsay method, was 272 micrograms/dl, both these values being in satisfactory agreement with the values of the respective interceptions of the straight lines represented by the above equations.
The reagent used contained from 0.5 to 10 gidI of basic magnesium carbonate, from 1 to 100 mg/dl of Fe3+ and from 0 to 200 mg/litre of
H2PO4.
Claims (12)
1. A method of determining the transferrine content of a sample suspected of containing transferrine, which method comprises mixing the sample with a reagent comprising a suspension of a solid substrate on which substrate a ferric salt is adsorbed, centrifuging the mixture, and determining the iron content of the resulting supernatant liquor.
2. A method according to claim 1, wherein the solid substrate is basic magnesium carbonate or calcium carbonate.
3. A method according to claim 1 or 2, wherein the reagent contains a buffer capable of maintaining the pH of the reagent at a value of from 8 to 9.
4. A method according to claim 3, wherein the buffer is phosphoric acid, a phosphate, barbituric acid or barbiturate.
5. A method according to any of claims 1 to 4, herein the reagent contains a colorimetric reagent for the determination of iron.
6. A method according to any of claims 1 to 5, wherein the sample comprises blood or blood serum.
7. A method according to claim 1, substantially as described in either of the foregoing Examples 1 and 2.
8. A reagent for use in determining the tranferrine content of a sample suspected of containing transferrine, the reagent comprising a suspension of a solid substrate on which substrate a ferric salt is adsorbed.
9. A reagent as claimed in claim 8, wherein the solid substrate is basic magnesium carbonate or calcium carbonate.
10. A reagent as claimed in claim 8 or 9, containing a buffer capable of maintaining the pH of the reagent at a value of from 8 to 9.
11. A reagent as claimed in claim 10, wherein the buffer is phophoric acid, a phosphate, barbituric acid or a barbiturate.
12. A reagent as claimed in any of claims 8 to 11, wherein the reagent contains a colorimetric reagent of the determination of iron.
1 3. A reagent as claimed in claim 8, substantially as described in either of the foregoing Examples 1 and 3.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT26564/80A IT1148745B (en) | 1980-12-11 | 1980-12-11 | METHOD FOR DETERMINING TRANSFERRINE AND COMPOSITION SUITABLE FOR THE PURPOSE |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2089505A true GB2089505A (en) | 1982-06-23 |
GB2089505B GB2089505B (en) | 1984-03-21 |
Family
ID=11219789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8136865A Expired GB2089505B (en) | 1980-12-11 | 1981-12-07 | Determination of transferrine |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS57122361A (en) |
CA (1) | CA1165215A (en) |
DE (1) | DE3147538C2 (en) |
ES (1) | ES508226A0 (en) |
FR (1) | FR2496270A1 (en) |
GB (1) | GB2089505B (en) |
IT (1) | IT1148745B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0137400A2 (en) * | 1983-09-26 | 1985-04-17 | Wako Pure Chemical Industries, Ltd. | Determination of unsaturated iron-binding capacity |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1239121B (en) * | 1964-01-29 | 1967-04-20 | Haury Chem Fab Dr Heinz | Method for determining the total iron-binding capacity of body fluids, especially serum and urine |
US3709985A (en) * | 1969-07-17 | 1973-01-09 | Abbott Lab | Method for determining total blood serum iron-binding capacity |
US3996162A (en) * | 1970-02-27 | 1976-12-07 | Nuclear Medical Laboratories, Inc. | Analytical sorbent and method of use |
JPS529160B2 (en) * | 1972-04-12 | 1977-03-14 | ||
JPS5913521B2 (en) * | 1975-06-19 | 1984-03-30 | メイトウサンギヨウ カブシキガイシヤ | Method for producing magnetic iron oxide/dextran complex |
US4154929A (en) * | 1976-08-16 | 1979-05-15 | American Monitor Corporation | 9-(2-Pyridyl)-acenaphtho[1,2-e]-as-triazines |
-
1980
- 1980-12-11 IT IT26564/80A patent/IT1148745B/en active
-
1981
- 1981-12-01 DE DE3147538A patent/DE3147538C2/en not_active Expired
- 1981-12-07 GB GB8136865A patent/GB2089505B/en not_active Expired
- 1981-12-07 CA CA000391654A patent/CA1165215A/en not_active Expired
- 1981-12-10 JP JP56197787A patent/JPS57122361A/en active Granted
- 1981-12-10 FR FR8123116A patent/FR2496270A1/en active Granted
- 1981-12-10 ES ES508226A patent/ES508226A0/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0137400A2 (en) * | 1983-09-26 | 1985-04-17 | Wako Pure Chemical Industries, Ltd. | Determination of unsaturated iron-binding capacity |
EP0137400A3 (en) * | 1983-09-26 | 1986-05-28 | Wako Pure Chemical Industries, Ltd. | Determination of unsaturated iron-binding capacity |
Also Published As
Publication number | Publication date |
---|---|
CA1165215A (en) | 1984-04-10 |
ES8303698A1 (en) | 1983-02-01 |
GB2089505B (en) | 1984-03-21 |
JPS57122361A (en) | 1982-07-30 |
JPH027429B2 (en) | 1990-02-19 |
IT1148745B (en) | 1986-12-03 |
ES508226A0 (en) | 1983-02-01 |
FR2496270B1 (en) | 1984-03-02 |
IT8026564A0 (en) | 1980-12-11 |
DE3147538A1 (en) | 1982-06-24 |
DE3147538C2 (en) | 1983-09-08 |
FR2496270A1 (en) | 1982-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weber et al. | The binding of calcium to actomyosin systems in relation to their biological activity | |
Halfman et al. | Measuring the binding of small molecules to protein from binding-induced alterations of physical-chemical properties | |
Tejwani et al. | The purification of properties of rat liver fructose 1, 6-bisphosphatase | |
Lehmann | Immunological relationship between human placentae and intestinal alkaline phosphatase | |
ZA832892B (en) | Ascorbate-resistant broad range glucose test compositions,test device and method | |
EP0290269A3 (en) | Immunoassay methods and reagents and methods for producing the latter | |
JP2000509486A (en) | One-step all-in-one dry reagent immunoassay | |
US5482866A (en) | Method for quantitation of calcium and magnesium and the novel reagent compositions | |
YU114287A (en) | Process for specific determining content of serum fructosamine, as well as reagent mixture which is suitable for this process | |
EP0108400A2 (en) | Determination of unsaturated thyroxine binding protein sites using fluorescence polarization techniques | |
US4486531A (en) | Method and reagent for the determination of β-lipoprotein | |
Long et al. | Kinetics and thermodynamics of the formation of glucose arsenate. Reaction of glucose arsenate with phosphoglucomutase | |
US4308027A (en) | Method and composition for direct determination of iron in blood serum | |
CA1140439A (en) | Quantitative testing for vitamin b in12 xx | |
CA1216216A (en) | Procedure for the determination of peroxidase activity by end dilution titration and means for its realization | |
US4567150A (en) | Method for determining transferrin and composition therefor | |
GB2089505A (en) | Determination of Transferrine | |
US4810656A (en) | Chromogenic reactive for determining the iron content and the iron-binding capacity of biological liquids | |
Mabuchi et al. | Actomyosin ATPase. I. Quantitative measurement of activity in cryostat sections | |
US4786591A (en) | Process for determining the binding capacity of thyroxin-binding globulin | |
US5219760A (en) | Process for the determination of iron | |
CA1128857A (en) | Dry composition of heavy metal cation with radiolabelled ligand and antibody | |
Hwang | Interference of ATP and acidity in the determination of inorganic phosphate by the Fiske and Subbarow method | |
Jacobsson | The effect of urea on the inhibition of trypsin by soybean trypsin inhibitor | |
US5443958A (en) | 2-acrylamine-2-methyl-1-propanesulfonic acid enhancement of alkaline phosphatase label detection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |